Research Project
Project Title: |
A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocomprom |
Project Type: |
Clinical Trial, Enrolment ongoing Adjunct biobank: Serum, Plasma |
Disease group(s): |
Pediatric kidney transplantation |
Project Summary: |
ZOSTER-047 will be conducted to evaluate the reactogenicity, safety and immunogenicity of 2 doses of PED-HZ/su (GlaxoSmithKline Biologicals SA’s [GSK’s] vaccine candidate for the prevention of HZ in immunocompromised paediatric population) in paediatric renal transplant recipients in age groups 1-11 and 12-17 years. |
Lead principal investigator(s): |
Giovanni Montini, Milan |
Co-investigator(s): |
Sara Testa, Milan |
Project Period: |
09/2019 - 09/2050 |
Sponsors: |
Industry |
Project web page: |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000607-33/IT |
EudraCT Nr.: |
2019-000607-33 |
« Back to research page